Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Common Stock | Options Exercise | $1.56M | +39.9K | +29.12% | $39.15 | 177K | Feb 16, 2023 | Direct | F1 |
transaction | SGEN | Common Stock | Sale | -$6.39M | -39.9K | -22.55% | $160.00 | 137K | Feb 16, 2023 | Direct | F1, F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -39.9K | -100% | $0.00* | 0 | Feb 16, 2023 | Common Stock | 39.9K | $39.15 | Direct | F4 |
Id | Content |
---|---|
F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $160.00 to $160.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
F4 | Options vested at a rate of 25% on 8/25/2016 and monthly thereafter until all the options were fully vested on 8/25/19. |